Instil Bio (TIL) Total Debt (2020 - 2026)

Instil Bio has reported Total Debt for 7 years, with the latest figure at $85.2 million in Q2 2026.

• On a quarterly basis, Total Debt rose 0.91% year-over-year to $85.2 million in Q2 2026; TTM through Jun 2026 was $85.2 million, a 0.91% increase from a year earlier, with the FY2025 full-year figure at $84.8 million, up 0.74% from the prior year.
• Total Debt was $85.2 million for Q2 2026 at Instil Bio, roughly flat from $85.0 million in the prior quarter.
• The five-year high for Total Debt was $85.2 million in Q2 2026, with the low at $867000.0 in Q1 2022.
• Average Total Debt over 5 years is $74.8 million, with a median of $81.8 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Total Debt slumped 38.38% in 2022, then jumped 8802.88% in 2023.
• Over 5 years, Total Debt stood at $72.7 million in 2022, then climbed by 11.99% to $81.4 million in 2023, then advanced by 3.39% to $84.2 million in 2024, then increased by 0.74% to $84.8 million in 2025, then advanced by 0.46% to $85.2 million in 2026.
• The last three Total Debt figures came in at $85.2 million (Q2 2026), $85.0 million (Q1 2026), and $84.8 million (Q4 2025), per Business Quant data.